太安堂(002433.SZ):擬終止出售康愛多47.35%股權相關事項
格隆匯1月28日丨太安堂(002433.SZ)公佈,公司以現金交易方式向成都醫雲科技有限公司(“成都醫雲”)出售其持有的廣東康愛多數字健康科技有限公司(“康愛多”或“標的公司”)47.35%的股權,同時將持有康愛多4%股權的表決權委託給成都醫雲行使。相關工商變更登記手續已辦理完畢,並於2021年7月6日換髮了新的營業執照,成都醫雲已按照《股權轉讓協議》及其補充協議的約定,向太安堂支付全部基準轉讓價款的60.00%,即4.49億元。截至公吿披露之日,雙方交易對價尚未結算完畢。
本次重大資產出售自啟動以來,交易各方積極推進本次重大資產出售工作。近期收到成都醫雲的説明,根據交易雙方的《股權轉讓協議》約定,經協商一致,決定終止本次重大資產出售事項。
公司於2022 年 1 月 28 日召開第五屆董事會第三十一次臨時會議、第五屆監事會第十九次臨時會議審議通過了《關於終止重大資產出售事項的議案》,同意公司終止本次重大資產出售事項並與交易對手成都醫雲簽署重大資產出售《終止暨還款協議》及《還款補充協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.